PubMed · 2001 · 232 citations · 22 references
Public HealthCommunity HealthInfectious Disease ControlHiv ControlHiv PreventionTuberculosis ControlAntiretroviral TherapyDirectly Observed TherapyEssential MedicinesHiv Care ContinuumHiv EpidemiologyHuman Immunodeficiency Virus PharmacotherapyAcquired Immunodeficiency SyndromeAntiretroviral Therapy CoverageCommunity-based Directly Observed TherapyCommunity-based Treatment AccessEarly Antiretroviral TherapyHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyHuman Immunodeficiency Virus Transmission
In 2000, acquired immunodeficiency syndrome (AIDS) overtook tuberculosis (TB) as the world's leading infectious cause of adult deaths. In affluent countries, however, AIDS mortality has dropped sharply, largely because of the use of highly active antiretroviral therapy (HAART). Antiretroviral agents are not yet considered essential medications by international public health experts and are not widely used in the poor countries where human immunodeficiency virus (HIV) takes its greatest toll. Arguments against the use of HAART have mainly been based on the high cost of medications and the lack of the infrastructure necessary for using them wisely. We re- examine these arguments in the setting of rising AIDS mortality in developing countries and falling drug prices, and describe a small community-based treatment programme based on lessons gained in TB control. With the collaboration of Haitian community health workers experienced in the delivery of home-based and directly observed treatment for TB, an AIDS-prevention project was expanded to deliver HAART to a subset of HIV patients deemed most likely to benefit. The inclusion criteria and preliminary results are presented. We conclude that directly observed therapy (DOT) with HAART, "DOT-HAART", can be delivered effectively in poor settings if there is an uninterrupted supply of high-quality drugs.
22
Community-based approaches to HIV treatment in resource-poor settings
Paul Farmer, Fèrnet Leandre, Joia S. Mukherjee et al. · The Lancet · 2001 · 523 citations
Public Health, Community Health, Infectious Disease Control +16
Shabir A. Madhi, Karen L. Petersen, A. Madhi et al. · Clinical Infectious Diseases · 2000 · 254 citations
Responding to Market Failures in Tuberculosis Control
Rajesh Gupta, Jim Y. Kim, Marcos Espinal et al. · Science · 2001 · 135 citations